Endo International (ENDP) Tops Q2 EPS by 17c, Offers FY Guidance

Endo International (NASDAQ: ENDP) reported Q2 EPS of $0.65, $0.17 better than the analyst estimate of $0.48. Revenue for the quarter came in at $714 million versus the consensus estimate of $661.86 million.

GUIDANCE:

Endo International sees FY2021 EPS of $2.15-$2.30, versus the consensus of $2.20. Endo International sees FY2021 revenue of $2.73-2.79 million, versus the consensus of $2.72 million.

For earnings history and earnings-related data on Endo International (ENDP) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Why UBS thinks this European chipmaker is still undervalued despite its premium valuation
• Profound Medical names Richard Fabian as president